WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing, Cancer Cell, vol.20, pp.768-780, 2011. ,
A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus, Proc Natl Acad Sci U S A, vol.99, pp.6023-6028, 2002. ,
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output, Blood, vol.118, pp.816-826, 2011. ,
Association between VEGF splice isoforms and progressionfree survival in metastatic colorectal cancer patients treated with bevacizumab, Clin Cancer Res, vol.18, pp.6384-6391, 2012. ,
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma, Cancer Res, vol.62, pp.4123-4131, 2002. ,
The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term, Clin Sci, vol.110, pp.575-585, 2006. ,
VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro, Am J Pathol, vol.183, pp.918-929, 2013. ,
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies, Clin Cancer Res, vol.19, pp.3681-3692, 2013. ,
)(1)b and VEGF(1)(6)(5)b are weakly angiogenic isoforms of VEGF-A, Mol Cancer, vol.9, issue.1, pp.320-327, 2010. ,
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis, Int J Cancer, vol.120, pp.2096-2109, 2007. ,
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2, Cell Mol Life Sci, vol.63, pp.2067-2077, 2006. ,
Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells, J Cell Biol, vol.188, pp.595-609, 2010. ,
Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes, Am J Obstet Gynecol, vol.173, pp.753-759, 1995. ,
Butyrate increases the formation of anti-angiogenic vascular endothelial growth factor variants in human lung microvascular endothelial cells, Mol Biol Rep, vol.37, pp.3729-3734, 2010. ,
Sam68-like mammalian protein 2, identified by digital differential display as expressed by podocytes, is induced in proteinuria and involved in splice site selection of vascular endothelial growth factor, J Am Soc Nephrol, vol.16, pp.1958-1965, 2005. ,
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein, Am J Physiol Renal Physiol, vol.286, pp.767-773, 2004. ,
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged, Genes Dev, vol.24, pp.2343-2364, 2010. ,
New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation, Angiogenesis, vol.16, pp.353-371, 2013. ,
Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis, Int J Cancer, vol.123, pp.1060-1067, 2008. ,
Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta, Mol Cell, vol.17, pp.429-439, 2005. ,
SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines, Cell Cycle, vol.10, pp.1968-1977, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02337383
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin, EMBO J, vol.30, pp.510-523, 2011. ,
Microenvironment changes (in pH) affect VEGF alternative splicing, Cancer Microenviron, vol.1, pp.131-139, 2008. ,
Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells, Mol Cancer Ther, vol.7, pp.3064-3070, 2008. ,
Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation, Bone, vol.42, pp.1092-1101, 2008. ,
URL : https://hal.archives-ouvertes.fr/ujm-00270279
Vascular endothelial growth factor: basic science and clinical progress, Endocr Rev, vol.25, pp.581-611, 2004. ,
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF, Cancer Sci, vol.101, pp.2483-2489, 2010. ,
Topical anti-angiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative-AMD, Invest Ophthalmol Vis Sci, vol.54, pp.6052-6062, 2013. ,
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma, PLoS One, vol.7, p.46539, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02337424
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines, Oncogene, vol.31, pp.1683-1694, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00824206
Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature, Mol Cell Biol, vol.20, pp.7282-7291, 2000. ,
Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206, Mol Biol Cell, vol.9, pp.875-884, 1998. ,
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth, J Exp Med, vol.209, pp.507-520, 2012. ,
VEGF-A splicing: the key to anti-angiogenic therapeutics?, Nat Rev Cancer, vol.8, pp.880-887, 2008. ,
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab, Clin Cancer Res, vol.19, pp.929-937, 2013. ,
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA, Mol Endocrinol, vol.5, pp.1806-1814, 1991. ,
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms, J Biol Chem, vol.267, pp.26031-26037, 1992. ,
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance, Clin Cancer Res, vol.19, pp.1773-1783, 2013. ,
Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor, Invest Ophthalmol Vis Sci, vol.40, pp.752-759, 1999. ,
VEGF121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small cell lung carcinoma patients, Lung Cancer, vol.59, pp.41-47, 2008. ,
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity, Cancer Res, vol.68, pp.4683-4692, 2008. ,
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency, J Biol Chem, vol.271, pp.7788-7795, 1996. ,
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm, Cancer Lett, vol.249, pp.133-142, 2007. ,
Markers of response for the antiangiogenic agent bevacizumab, J Clin Oncol, vol.31, pp.1219-1230, 2013. ,
Possible participation of pICln in the regulation of angiogenesis through alternative splicing of vascular endothelial growth factor receptor mRNAs, Endothelium, vol.11, pp.293-300, 2004. ,
Expression of vascular endothelial growth factor isoforms and plateletderived endothelial cell growth factor in bladder cancer, Urol Oncol, vol.6, pp.10-15, 2000. ,
Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development, Cell, vol.140, pp.268-279, 2010. ,
Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma, Urol Res, vol.31, pp.335-340, 2003. ,
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex, Cancer Cell, vol.22, pp.21-35, 2012. ,
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis, Circ Res, vol.109, pp.14-26, 2011. ,
Alternative splicing variant of vascular endothelial growth factor-A is a critical prognostic factor in non-small cell lung cancer, Oncol Rep, vol.22, pp.1407-1413, 2009. ,
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo, Oncogene, vol.29, pp.5392-5403, 2010. ,
5-Aza-2'-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells, Biomed Pharmacother, vol.62, pp.158-163, 2008. ,
Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents, J Cell Biol, vol.179, pp.1261-1273, 2007. ,
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia, Int J Biol Markers, vol.24, pp.22-31, 2009. ,
Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site, Proc Natl Acad Sci U S A, vol.94, pp.7192-7197, 1997. ,
Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib, Cancer Res, vol.70, pp.2171-2179, 2010. ,
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis, J Biol Chem, vol.285, pp.5532-5540, 2010. ,
Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors, J Cell Sci, vol.121, pp.3487-3495, 2008. ,
Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer, Clin Cancer Res, vol.2, pp.1411-1416, 1996. ,
Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer, Int J Oncol, vol.12, pp.541-544, 1998. ,
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung, J Clin Oncol, vol.30, pp.1129-1136, 2012. ,
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth, Cancer Cell, vol.11, pp.53-67, 2007. ,
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting, J Biol Chem, vol.282, pp.24049-24056, 2007. ,
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing, Nat Genet, vol.40, pp.1413-1415, 2008. ,
Balance of pro-versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth, J Pathol, vol.222, pp.138-147, 2010. ,
Diabetic retinopathy is associated with a switch in splicing from anti-to pro-angiogenic isoforms of vascular endothelial growth factor, Diabetologia, vol.48, pp.2422-2427, 2005. ,
Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect, J Biol Chem, vol.272, pp.13390-13396, 1997. ,
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma, Br J Cancer, vol.97, pp.223-230, 2007. ,
The anti-angiogenic isoforms of VEGF in health and disease, Biochem Soc Trans, vol.37, pp.1207-1213, 2009. ,
Treatment-related mortality with bevacizumab in cancer patients: a metaanalysis, JAMA, vol.305, pp.487-494, 2011. ,
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice, Br J Cancer, vol.98, pp.1250-1257, 2008. ,
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo, Br J Cancer, vol.101, pp.1183-1193, 2009. ,
Vascular endothelial growth factor (VEGF) signaling in tumor progression, Crit Rev Oncol Hematol, vol.62, pp.179-213, 2007. ,
VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing, FEBS Lett, vol.587, pp.2179-2185, 2013. ,
Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors, J Clin Oncol, vol.30, pp.871-877, 2012. ,
Inhibition of neovascularization and expression shift of pro-/antiangiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model, Chin Med J (Engl), vol.126, pp.345-352, 2013. ,
VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding, J Cell Biochem, vol.85, pp.357-368, 2002. ,
Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer, World J Gastroenterol, vol.17, pp.4867-4874, 2011. ,
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors, Cancer Res, vol.68, pp.2301-2311, 2008. ,
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro-and antiangiogenic VEGF-A isoforms has implications for therapy, Br J Cancer, vol.98, pp.1366-1379, 2008. ,
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21, Circulation, vol.3, pp.1493-1495, 1996. ,
Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions, Cell Adh Migr, vol.5, pp.332-343, 2011. ,
Identification of an exonic splicing silencer in exon 6A of the human VEGF gene, BMC Mol Biol, vol.10, pp.103-109, 2009. ,
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression, Cancer Res, vol.64, pp.7822-7835, 2004. ,
Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE-and SSCE-MRI, PLoS One, vol.6, p.16062, 2001. ,
Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease, Clin Biochem, vol.41, pp.82-87, 2008. ,
Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer, Clin Chem, vol.53, pp.1433-1439, 2007. ,